We are live on ! Find out more
NYMX

Nymox Pharmaceutical Corp
NYMX

Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

37 hedge funds and large institutions have $444K invested in Nymox Pharmaceutical Corp in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more call options, than puts

Call options by funds: $16K | Put options by funds: $2K

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

9% more funds holding

Funds holding: 34 → 37 (+3)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

10% less capital invested

Capital invested by funds: $495K → $444K (-$50.9K)

Holders
37
Holders Change
+3
Holders Change %
+8.82%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
8
Closed
5
Calls
$16K
Puts
$2K
Net Calls
+$14K
Net Calls Change
+$16K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$30.5K
2
Renaissance Technologies
Renaissance Technologies
New York
+$30K
3
CAN
Cetera Advisor Networks
California
+$18.1K
4
Jane Street
Jane Street
New York
+$9.1K
5
VF
Virtu Financial
New York
+$7.11K

Top Sellers

Rank Fund Capital Flow
1
LSA
Leonteq Securities AG
Switzerland
-$27.4K
2
Millennium Management
Millennium Management
New York
-$16K
3
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$14.6K
4
GG
Gofen & Glossberg
Illinois
-$9.05K
5
WCWM
Willow Creek Wealth Management
California
-$8K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$3K -$105 -289 -3%
ODIJL
27
One Day In July LLC
Vermont
$2.97K – – –
CS
28
Credit Suisse
Switzerland
$2.23K +$2.71K +7,490 New
Rockefeller Capital Management
29
Rockefeller Capital Management
New York
$2K +$1.81K +5,000 +250%
BWA
30
BDO Wealth Advisors
Florida
$1.52K – – –
Group One Trading
31
Group One Trading
Illinois
$1.47K -$366 -1,010 -17%
Wells Fargo
32
Wells Fargo
California
$1K -$4.13K -11,397 -79%
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
$389 – – –
PA
34
PSI Advisors
Florida
$388 +$72 +200 +20%
UBS Group
35
UBS Group
Switzerland
$120 – – –
Bank of America
36
Bank of America
North Carolina
$114 -$330 -912 -72%
LSA
37
Leonteq Securities AG
Switzerland
– -$27.4K -64,999 Closed
Millennium Management
38
Millennium Management
New York
– -$16K -38,068 Closed
WCWM
39
Willow Creek Wealth Management
California
– -$8K -18,724 Closed
Simplex Trading
40
Simplex Trading
Illinois
– -$403 -1,113 Closed
SFG
41
Steward Financial Group
Texas
– +$36 +100 New
1
2

NYMX Hedge Fund Activity: Q4 2022 in Review

37 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q4 2022, worth a combined $444K — down 10% from $495K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new NYMX positions and 5 closed out — a net gain of 3 holders — while 8 added to existing stakes and 8 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $30.5K. The largest seller was Leonteq Securities AG, exiting entirely with an estimated $27.4K sold.

  • 37 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q4 2022, up from 34 in Q3 2022.
  • Funds reported $444K of Nymox Pharmaceutical Corp stock for Q4 2022, down 10% quarter-over-quarter.
  • 8 funds opened new Nymox Pharmaceutical Corp positions in Q4 2022 and 5 closed out, a net change of +3 holders.
  • The largest Nymox Pharmaceutical Corp buyer in Q4 2022 was Citadel Advisors, an estimated $30.5K added.
  • The largest Nymox Pharmaceutical Corp seller in Q4 2022 was Leonteq Securities AG, an estimated $27.4K sold.

Based on aggregated 13F filings for Q4 2022.